Today at the American Association for Cancer Research in Orlando, Ken presented his poster on The role of protein kinase Cι in alveolar rhabdomyosarcoma. Charles also began his term on the tumor microenvironment (TME) steering committee.
An emerging theme is that targeted (non-chemotherapy) drugs probably need to be given in combination for most solid tumors, and that the complexity of cancer and nearby non-cancerous tissue needs to be considered for targeted treatment, too.